C Vogel

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.

Simon A. Jones, Eric P. Winer, C Vogel et al. · Journal of Clinical Oncology · 1995 · 193 citations

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older

C Vogel, M OROURKE, Eric P. Winer et al. · Annals of Oncology · 1999 · 114 citations · Full text

Advanced Breast Cancer, Breast Oncology, Medicine +8

First line, non-hormonal treatment of women with HER2 overexpressing metastatic breast cancer with herceptin (trastuzumab, humanized anti-HER2 antibody)

C Vogel · Medical Entomology and Zoology · 2000 · 56 citations

Metastatic Breast Cancer, Non-hormonal Treatment, Breast Oncology +9

A phase II study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer.

S. Vukelja, Hope S. Rugo, C Vogel et al. · Cancer Research · 2009 · 27 citations

Breast Oncology, Immunology, Phase Ii Study +20

Color Doppler Sonographic Dynamic Tissue Perfusion Measurement Demonstrates Significantly Reduced Cortical Perfusion in Children with Diabetes Mellitus Type 1 without Microalbuminuria and Apparently Healthy Kidneys

T. Scholbach, C Vogel, N. Bergner · Ultraschall in der Medizin - European Journal of Ultrasound · 2014 · 11 citations